...
首页> 外文期刊>European Journal of Medicinal Chemistry: Chimie Therapeutique >Phenylpyrrole derivatives as neural and inducible nitric oxide synthase (nNOS and iNOS) inhibitors.
【24h】

Phenylpyrrole derivatives as neural and inducible nitric oxide synthase (nNOS and iNOS) inhibitors.

机译:苯基吡咯衍生物作为神经和诱导型一氧化氮合酶(nNOS和iNOS)抑制剂。

获取原文
获取原文并翻译 | 示例
           

摘要

We have previously described a series of 3-phenyl-4,5-dihydro-1H-pyrazole derivatives as moderately potent nNOS inhibitors. As a follow up of these studies, several new 5-phenyl-1H-pyrrole-2-carboxamide derivatives have been synthesized, and their biological evaluation as in vitro inhibitors of both neural and inducible Nitric Oxide Synthase (nNOS and iNOS) is described. Some of these compounds show good iNOSNOS selectivity and the more potent compounds 5-(2-aminophenyl)-1H-pyrrole-2-carboxilic acid methylamide (QFF205) and cyclopentylamide (QFF212) have been tested as regulators of the in vivo nNOS and iNOS activity. Both compounds prevented the increment of the inducible NOS activity in both cytosol (iNOS) and mitochondria (i-mtNOS) observed in the MPTP model of Parkinson's disease.
机译:我们先前已经描述了一系列3-苯基-4,5-二氢-1H-吡唑衍生物作为中度有效的nNOS抑制剂。作为这些研究的后续,已合成了几种新的5-苯基-1H-吡咯-2-羧酰胺衍生物,并描述了它们作为神经和诱导型一氧化氮合酶(nNOS和iNOS)的体外抑制剂的生物学评估。这些化合物中的一些显示出良好的iNOS / nNOS选择性,更有效的化合物5-(2-氨基苯基)-1H-吡咯-2-羧甲基甲酰胺(QFF205)和环戊酰胺(QFF212)已作为体内nNOS的调节剂进行了测试。和iNOS活动。在帕金森氏病的MPTP模型中观察到,两种化合物均阻止了胞质溶胶(iNOS)和线粒体(i-mtNOS)诱导型NOS活性的增加。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号